NOTE TO READERS: When this project lost substantial funding at the end of 2018, I lost the ability to continue publishing criteria-driven news story reviews and PR news release reviews - once the bread-and-butter of the site going back to 2006. The 3,200 archived reviews, while still educational, are getting old and difficult for me to technically maintain on the back end of the website. So I am announcing that I plan to remove these reviews from the site by April 1, 2021. The blog and the toolkit - two of the most popular features on the site - will remain. If you wish to peruse the reviews before they disappear, please do so by the end of March 2021. After that date you may still be able to access them via the Internet Archive Wayback Machine - https://archive.org/web/.

Tags: blood test

11/20/2018

News release far too rosy/conflicted for small study on ovarian cancer test

9/19/2018

University PR misleads with claim that preliminary blood test detects early pancreatic cancer

8/20/2018

NIH brings balance to recap of study on blood test for gestational diabetes

8/1/2018

Claims surrounding new brain injury blood test short on evidence

7/5/2018

Announcement oversells blood test for predicting treatment outcomes in prostate cancer

6/28/2018

Pilot study on cerebral palsy blood test heralded as ‘breakthrough’ and ‘game changer’

1 2/22/2018

Potential harms and source of evidence missing in FDA summary of new blood test for concussion

11/2/2017

‘Breakthrough’ in multiple sclerosis diagnostic? Not so fast.

11/15/2016

PR release calls concussion blood test a ‘game changer’ — based on study involving 12 head injuries

4/13/2016

Blood screening test for liver fibrosis billed as a “breakthrough.” Not so fast.